| Dr Joseph Tylor Silvers, DO | |
|
446 W Cumberland Gap Pkwy, Corbin, KY 40701-4819 | |
| (606) 523-1565 | |
| (606) 526-5828 |
| Full Name | Dr Joseph Tylor Silvers |
|---|---|
| Gender | Male |
| Speciality | Sports Medicine |
| Experience | 12 Years |
| Location | 446 W Cumberland Gap Pkwy, Corbin, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003170713 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Corbin | Corbin, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
News Archive
Access Pharmaceuticals, Inc., a biopharmaceutical company specializing in products for cancer and supportive care signed a $30 million supply agreement for MuGard with RHEI Pharmaceuticals, Inc., a specialty pharmaceutical company focused on bringing proprietary medicines to the China market. Access will ensure manufacturing capacity of up to a minimum of $30 million of product in the licensed territories.
A new study published in February 2020 in the journal JAMA Otolaryngology-Head and Neck Surgery shows that using mainstream media to depict rare diseases in a realistic manner can prompt greater public awareness and support for such conditions.
Research published by scientists at the University of California, Riverside on "fear memory" could lead to the development of therapies that reduce the effects of post-traumatic stress disorder (PTSD).
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
› Verified 9 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518360296 PECOS PAC ID: 5597867184 Enrollment ID: O20150206000249 |
News Archive
Access Pharmaceuticals, Inc., a biopharmaceutical company specializing in products for cancer and supportive care signed a $30 million supply agreement for MuGard with RHEI Pharmaceuticals, Inc., a specialty pharmaceutical company focused on bringing proprietary medicines to the China market. Access will ensure manufacturing capacity of up to a minimum of $30 million of product in the licensed territories.
A new study published in February 2020 in the journal JAMA Otolaryngology-Head and Neck Surgery shows that using mainstream media to depict rare diseases in a realistic manner can prompt greater public awareness and support for such conditions.
Research published by scientists at the University of California, Riverside on "fear memory" could lead to the development of therapies that reduce the effects of post-traumatic stress disorder (PTSD).
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Tylor Silvers, DO Po Box 936, London, KY 40743-0936 Ph: () - | Dr Joseph Tylor Silvers, DO 446 W Cumberland Gap Pkwy, Corbin, KY 40701-4819 Ph: (606) 523-1565 |
News Archive
Access Pharmaceuticals, Inc., a biopharmaceutical company specializing in products for cancer and supportive care signed a $30 million supply agreement for MuGard with RHEI Pharmaceuticals, Inc., a specialty pharmaceutical company focused on bringing proprietary medicines to the China market. Access will ensure manufacturing capacity of up to a minimum of $30 million of product in the licensed territories.
A new study published in February 2020 in the journal JAMA Otolaryngology-Head and Neck Surgery shows that using mainstream media to depict rare diseases in a realistic manner can prompt greater public awareness and support for such conditions.
Research published by scientists at the University of California, Riverside on "fear memory" could lead to the development of therapies that reduce the effects of post-traumatic stress disorder (PTSD).
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
› Verified 9 days ago
Dr. Bruce R Jung, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 46 Marisa Ct, Corbin, KY 40701 Phone: 606-280-1514 | |
David L Winkle, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 95 Bryan Blvd, Corbin, KY 40701 Phone: 606-526-4590 Fax: 606-526-0548 | |
Dr. Cherie O. Gambrel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14949 N Us Highway 25 E, Ste. 4, Corbin, KY 40701 Phone: 606-528-0305 Fax: 606-523-4368 | |
Mr. Roger Wayne May, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 610 Laurel Lake Resort Rd, Ste 2, Corbin, KY 40701 Phone: 606-515-7137 Fax: 606-258-8211 | |
Jessica Bennett, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 96 Future Dr, Corbin, KY 40701 Phone: 606-528-0305 | |
Dr. Nikhil Sharad Parulekar, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 141 East Cumberland Gap Pkwy., Corbin, KY 40701 Phone: 606-528-1234 Fax: 606-528-2727 |